富祥药业拟授出不超620万份股票期权

Group 1 - The company, Fuxiang Pharmaceutical (300497.SZ), has disclosed a draft for its first stock option incentive plan, proposing to grant up to 6.2 million stock options to incentive recipients [1] - The initial grant will not exceed 5.05 million stock options, with an exercise price set at 16.15 yuan per share [1] - The plan's validity period will last from the date of the first stock option grant until all granted options are exercised or canceled, with a maximum duration of 60 months [1]